Sort
15,842 grants matching “pancreatic cancer”
Targeting pancreatic cancer's metabolic addiction to HuR
$373,116Jordan M Winter · Case Western Reserve University · R37 · FY2022 · CA
Targeting pancreatic cancer's metabolic addiction to HuR
$373,116Jordan M Winter · Case Western Reserve University · R37 · FY2020 · CA
Targeting pancreatic cancer's metabolic addiction to HuR
$373,116Jordan M Winter · Case Western Reserve University · R37 · FY2021 · CA
Project 1 â IL-6/STAT3/NF-kB in Adipose-Muscle Crosstalk in the Pancreatic Cancer Macroenvironment
$373,047Teresa A Zimmers · Medical University Of South Carolina · P01 · FY2022 · CA
Transcriptional Regulators of Exocrine Pancreatic Development
$373,032Raymond J. Macdonald · Ut Southwestern Medical Center · R01 · FY2010 · DK
Accessible high-throughput single-cell genome sequencing
$372,994Andrew Adey · Oregon Health & Science University · R33 · FY2023 · CA
EX VIVO DIFFERENTIATION AND EXPANSION OF ADULT PANCREATIC COLONY-FORMING UNITS
$372,960Hsun Teresa Ku · Beckman Research Institute/City Of Hope · R01 · FY2017 · DK
EX VIVO DIFFERENTIATION AND EXPANSION OF ADULT PANCREATIC COLONY-FORMING UNITS
$372,960Hsun Teresa Ku · Beckman Research Institute/City Of Hope · R01 · FY2015 · DK
EX VIVO DIFFERENTIATION AND EXPANSION OF ADULT PANCREATIC COLONY-FORMING UNITS
$372,960Hsun Teresa Ku · Beckman Research Institute/City Of Hope · R01 · FY2016 · DK
EX VIVO DIFFERENTIATION AND EXPANSION OF ADULT PANCREATIC COLONY-FORMING UNITS
$372,960Hsun Teresa Ku · Beckman Research Institute/City Of Hope · R01 · FY2018 · DK
EX VIVO DIFFERENTIATION AND EXPANSION OF ADULT PANCREATIC COLONY-FORMING UNITS
$372,960Hsun Teresa Ku · Beckman Research Institute/City Of Hope · R01 · FY2014 · DK
Developing MRI-Guided Preventive Dendritic Cell Vaccination Strategy to Avoid Post-surgical Pancreatic Cancer Recurrence and Metastasis
$372,875Zhuoli Zhang · University Of California-Irvine · R01 · FY2024 · CA
Combined siRNA Therapy and In-vivo Imaging in Islet Transplantation
$372,874Anna Moore · Massachusetts General Hospital · R01 · FY2008 · DK
Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer
$372,824Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2018 · CA
Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells
$372,796Yingxiao Wang · University Of California, San Diego · R33 · FY2019 · CA
Basic Science Research in Digestive Diseases
$372,772Mark Donowitz · Johns Hopkins University · T32 · FY2009 · DK
Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer
$372,748Jonathan Brody · Thomas Jefferson University · R01 · FY2018 · CA
Targeting MUC1-induced Tumor-stromal Metabolic Cross-talk in Pancreatic Cancer
$372,693Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2015 · CA
Using FAP to Selectively Target Epithelial Cancers
$372,632William W Bachovchin · Tufts University Boston · R01 · FY2012 · CA
Exosomes in Cancer Therapy
$372,618Raghu Kalluri · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Synergistic chemo-siRNA combination therapy
$372,483M Guillaume Wientjes · Optimum Therapeutics, Llc · R01 · FY2015 · CA
Synergistic chemo-siRNA combination therapy
$372,483M Guillaume Wientjes · Optimum Therapeutics, Llc · R01 · FY2012 · CA
Synergistic chemo-siRNA combination therapy
$372,483M Guillaume Wientjes · Optimum Therapeutics, Llc · R01 · FY2011 · CA
Development of Molecularly Targeted Imaging Agents for KRAS activity in vivo
$372,465Kimberly A. Kelly · University Of Virginia · R01 · FY2010 · EB
The biosynthesis of N-N bond-containing natural products
$372,422Emily Patricia Balskus · Harvard University · R01 · FY2022 · GM